World Pharma News Digest - 14.09.2009

0 views
Skip to first unread message

Ruslan David

unread,
Sep 14, 2009, 5:18:50 AM9/14/09
to worldph...@googlegroups.com
New data show patients with chronic low back pain maintained pain reduction on duloxetine 
New data show patients with chronic low back pain on duloxetine hydrochloride (Cymbalta®) maintained reductions in pain for 41 weeks.(1) In patients who initially responded to duloxetine, this maintenance of pain reduction was accompanied by further reduction in pain that was statistically significant as measured by the Brief Pain Inventory (BPI) average pain rating.(1) 
Read more... 
http://www.worldpharmanews.com/content/view/935/1/
 
EU-funded study finds pandemic swine flu infects cells deep inside lungs 
Which type of flu infects cells deep inside the lungs: pandemic swine or seasonal? EU-funded researchers say pandemic swine flu wins hands down. Published in the journal Nature Biotechnology, the findings of a new study suggest that humans infected with the pandemic strain of swine-origin H1N1 influenza will probably experience more severe symptoms than patients infected with the seasonal strain of H1N1 because of how the swine virus attaches to specific receptors in the body. 
Read more... 
http://www.worldpharmanews.com/content/view/934/1/
 
Abbott to Acquire Evalve, Inc., a Leader in Minimally Invasive Cardiac Valve Repair Technology 
Abbott (NYSE: ABT) has announced a definitive agreement to acquire the outstanding equity of Evalve, Inc., the global leader in the development of devices for minimally invasive repair of cardiac mitral valves. The acquisition provides Abbott with a presence in the growing area of non-surgical treatment for structural heart disease, in which physicians use catheter-based devices to repair or replace basic structural components of the heart such as mitral and aortic valves. 
Read more... 
http://www.worldpharmanews.com/content/view/933/1/
 
FDA Advisory Committee makes favorable recommendation for Cervarix 
GlaxoSmithKline (NYSE: GSK) has announced that the U.S. Food and Drug Administration's (FDA) Vaccines and Related Biological Products Advisory Committee (VRBPAC) voted that clinical data support both the efficacy and safety of CERVARIX®, the company's candidate cervical cancer vaccine (12-1 and 11-1, respectively). 
Read more... 
http://www.worldpharmanews.com/content/view/932/1/
 
Essential ePharma Trends and Strategies for Marketing to Physicians and Patients in 2010 
Pharmaceutical and healthcare market research company Manhattan Research releases a new white paper, "How Digital is Shaping the Future of Pharmaceutical Marketing". In this new complimentary report, Manhattan Research takes a broad look at the most important eHealth trends from their four U.S.-based physician and consumer studies. 
Read more... 
http://www.worldpharmanews.com/content/view/931/1/
 
Online Video Library Launched To Share Martha Beck's Experience Living with Fibromyalgia 
For people living with painful conditions, September is a time for their true stories of triumph to emerge. Helping to foster support and communication, National Pain Awareness Month allows people with painful conditions to educate others about their experiences, build connections and together fight their pain. 
Read more... 
http://www.worldpharmanews.com/content/view/930/1/
 
Abbott Again Named One of the 'Best Places to Launch a Career' by BusinessWeek 
For the fourth consecutive year, Abbott (NYSE: ABT) has been named one of the "50 Best Places to Launch a Career" by BusinessWeek magazine. The list highlights companies that excel at offering a superior workplace for entry-level employees. This year, Abbott moved up to No. 13, and was once again the top-ranked health care company on the list. 
Read more... 
http://www.worldpharmanews.com/content/view/929/1/
 
Study reveals gene behind insulin resistance 
EU-funded researchers have identified a human genetic variant that raises the risk of developing type 2 diabetes. The findings add to our understanding of the factors behind the condition, and could lead to the development of new treatments. The study is published in the journal Nature Genetics. 
Read more... 
http://www.worldpharmanews.com/content/view/928/1/
 
PharmaNews.eu / Latest News
 
 
 
 
Sanofi Pasteur and Butantan Institute to Provide A(H1N1) Vaccine to Brazilian Government
http://www.pharmanews.eu/sanofi-aventis/317-sanofi-pasteur-and-butantan-institute-to-provide-ah1n1-vaccine-to-brazilian-government
 
 
 
 
MabThera approved in Europe for use in patients with previously-treated chronic lymphocytic leukaemia
http://www.pharmanews.eu/roche/313-mabthera-approved-in-europe-for-use-in-patients-with-previously-treated-chronic-lymphocytic-leukaemia
 
 
 
With best regards,
Ruslan David, MD
Administrator/Editor
 
 
PS:
Subscribe to World Pharma News alerts by Email (a free service delivered by Google) -
http://feedburner.google.com/fb/a/mailverify?uri=worldpharmanews&loc=en_US
 
Subscribe to PharmaNews.eu alerts by Email (a free service delivered by Google) -
http://feedburner.google.com/fb/a/mailverify?uri=pharmanewseu&loc=en_US
Reply all
Reply to author
Forward
0 new messages